GENFIT
GENFIT, a biopharmaceutical company headquartered in France, is at the forefront of developing innovative therapies for metabolic and liver diseases. Founded in 2008, the company has made significant strides in the industry, particularly with its focus on non-alcoholic steatohepatitis (NASH) and other related conditions. With a robust pipeline of clinical programmes, GENFIT's core products, including its lead candidate elafibranor, are designed to address unmet medical needs in liver health. The company distinguishes itself through its commitment to precision medicine and the integration of advanced biomarkers in its research. Recognised for its expertise, GENFIT has established a strong market position, contributing to the evolving landscape of liver disease treatment. Its dedication to innovation and patient-centric solutions continues to drive its success in the biopharmaceutical sector.
DitchCarbon Score
How does GENFIT's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GENFIT's score of 19 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GENFIT's reported carbon emissions
In 2023, GENFIT reported total carbon emissions of approximately 1,559,000 kg CO2e, comprising 663,000 kg CO2e from Scope 1, 92,000 kg CO2e from Scope 2, and 804,000 kg CO2e from Scope 3 emissions. This reflects a slight decrease in Scope 1 emissions compared to 2022, where they were about 700,000 kg CO2e. In 2022, GENFIT's total emissions were approximately 1,577,000 kg CO2e, with Scope 1 emissions at 700,000 kg CO2e, Scope 2 at 101,000 kg CO2e, and Scope 3 at 776,000 kg CO2e. The company has shown a commitment to monitoring and reporting its emissions across all relevant scopes, although no specific reduction targets or initiatives have been disclosed. Overall, GENFIT's emissions data indicates a focus on transparency in their carbon footprint, but further details on reduction strategies or climate pledges are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 627,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 110,000 | 000,000 | 000,000 | 00,000 |
| Scope 3 | - | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GENFIT is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
